Beyeonics

Executive Summary

Beyeonics is an Israeli med-tech startup revolutionizing ophthalmic surgery through augmented reality (AR) and high-resolution imaging. Founded in 2020 and based in Caesarea, the company develops advanced visualization platforms that provide surgeons with real-time, three-dimensional views of ocular structures during cataract, retinal, and corneal procedures. By overlaying digital guidance onto the surgical field, Beyeonics aims to enhance precision, reduce complications, and improve patient outcomes. The company targets both hospital and private-practice eye-care markets, positioning itself as a key player in the growing digital surgery space. The platform's competitive advantage lies in its proprietary AR technology, which integrates seamlessly with existing surgical microscopes, offering an intuitive and immersive experience without disrupting workflow. Beyeonics addresses a critical need for better visualization in microsurgery, where depth perception and accuracy are paramount. With a lean team of 10–50 employees and a platform-stage business model, the company is well-positioned for rapid adoption as ophthalmology moves toward digital transformation. Key growth drivers include increasing demand for minimally invasive surgeries, aging populations, and the shift toward value-based care. While still in its early commercial phase, Beyeonics has the potential to become a standard tool in ophthalmic operating rooms globally.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for AR surgical visualization platform65% success
• Q2 2026Series B funding round led by strategic healthcare investors70% success
• Q1 2027Strategic partnership with a leading ophthalmic device manufacturer50% success